Willow Biosciences Announces Expansion of its Commercial Operations Team and Development Portfolio, an Update on its Intellectual Property Position, and Formation of ESG Committee
Early research indicates that CBN may be effective as a sleep aid or sedative, in addition to other potential health benefits.
- Early research indicates that CBN may be effective as a sleep aid or sedative, in addition to other potential health benefits.
- As Willow's team and operations grow, Willow continues to invest in its industry-leading sustainability management capabilities.
- The ESG committee is comprised of cross-functional representatives and meets quarterly to ensure consistent progress.
- ESG priorities for Willow in 2021 and 2022 include ESG strategy development, data management on identified safety, environmental, and social KPIs, target-setting, and internal and external stakeholder engagement.